Find Research Projects

Search results

• A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROL

  Young, J. H.

  Chimerix, Inc.

  11/17/09 → 9/29/12

  Project: Research project

• A Multicenter, Randomized, Double-Blind, Placebo-Control

  Burmeister, L. A.

  EISAI MEDICAL RESEARCH INC.

  2/15/11 → 12/31/15

  Project: Research project

• A Multicenter, Randomized, Double-Blind, Placebo-Control

  Makhlouf, A.

  BRISTOL-MYERS SQUIBB COMPANY

  10/25/06 → 12/31/08

  Project: Research project

• A Multicenter, Randomized, Double-Blind, Placebo-Control

  Adson, D. E. & Beyer, T.

  BRISTOL-MYERS SQUIBB COMPANY

  3/28/05 → 12/31/08

  Project: Research project

• A Multicenter, Randomized, Double-Blind, Placebo-Control

  Hirsch, A. T.

  AASTROM BIOSCIENCES, INC.

  3/1/12 → 2/28/14

  Project: Research project

• A Multicenter, Randomized, Double-Blind, Placebo-Control

  Walk, D.

  JOHNSON AND JOHNSON MED INC

  8/20/09 → 1/19/14

  Project: Research project

• A Multicenter, Randomized, Double-blind, Placebo-control

  Sudel, B.

  Forest Research Institute

  11/1/15 → 10/31/19

  Project: Research project

• A Multicenter, Randomized, Double-blind, Placebo-control

  Nathan, B. M. & Bensignor, M. O.

  The EMMES Corporation

  5/1/18 → 10/31/22

  Project: Research project

• A Multicenter, Randomized, Double-blind, Placebo-control

  Sudel, B.

  Forest Research Institute

  11/1/15 → 10/31/19

  Project: Research project

• A multicenter, randomized, double-blind, placebo-control

  Fujioka, N.

  EMD Serono, Inc.

  1/28/14 → 9/30/14

  Project: Research project

• A multicenter, randomized, double-blind, placebo-control

  Regelmann, W. E.

  Genentech Inc.

  11/13/06 → 12/31/09

  Project: Research project

• A Multicenter, Randomized, Double-blind, Placebo control

  Pritzker, M. R.

  IRONWOOD PHARMACEUTICALS, INC

  1/1/18 → 1/30/21

  Project: Research project

• A Multi-Center, Randomized, Double-Blind, Placebo-Contro

  Hertz, M. I.

  Alnylam Pharmaceuticals, Inc.

  12/18/07 → 12/31/20

  Project: Research project

• A Multi-Center, Randomized, Double-Blind, Placebo-Contro

  Tuite, P. J.

  IQVIA, INC

  9/7/06 → 11/9/08

  Project: Research project

• A Multi-center, Randomized, Double-Blind, Placebo-Contro

  Hertz, M. I.

  APT Pharmaceuticals, Inc.

  2/18/08 → 12/31/12

  Project: Research project

• A multi-center, randomized, double-blind, placebo-contro

  Kim, S. W. & Grant, J.

  Transcept Pharmaceuticals, Inc.

  11/15/10 → 6/30/14

  Project: Research project

• A Multicenter, Randomized, Double-Blind, Phase 3 Study O

  Kratzke, R. A.

  PFIZER, INC.

  3/27/08 → 12/31/20

  Project: Research project

• A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction of 40%

  Alexy, T.

  BAYER HEALTHCARE PHARMACEUTICALS

  7/1/20 → 7/31/24

  Project: Research project

• A Multicenter, Randomized, Double-Blind, Parallel-Group,

  Parry, G. J. & Carpenter, A.

  BIOGEN INC

  5/1/09 → 3/31/13

  Project: Research project

• A multicenter, randomized, double-blind, parallel-group,

  Beaver, G.

  NOVARTIS PHARMACEUTICALS CORPORATION

  3/1/13 → 6/30/17

  Project: Research project

• A Multicenter, Randomized, Double-blind, Parallel Group,

  Rittberg, B. R. & Crow, S. J.

  AstraZeneca

  12/19/12 → 12/9/13

  Project: Research project

• A multicenter, randomized, double-blind, parallel group,

  Cogswell, R. J.

  Novartis Pharma AG

  5/1/14 → 3/1/20

  Project: Research project

• A Multicenter, Randomized, Double-blind, Parallel-group

  Tuite, P. J.

  SOLVAY PHARM

  1/4/07 → 8/24/08

  Project: Research project

• A multi-center, randomized, double-blind, 52-week study

  Reilkoff, R. A.

  NOVARTIS PHARMACEUTICALS CORPORATION

  9/1/12 → 12/31/14

  Project: Research project

• A Multicenter, Randomized, Double-Blind, "Crossover" Des

  Duprez, D.

  MERCK AND CO INC

  9/10/07 → 3/10/09

  Project: Research project

• A Multi-Center, Randomized, Controlled, Double-Blind Stu

  Dunitz, J. M.

  Seattle Children's Hospital

  6/27/13 → 1/1/17

  Project: Research project

• A Multicenter, Randomised, Double-Blind, Comparative Stu

  Young, J. H.

  MERCK

  1/1/06 → 1/1/08

  Project: Research project

• A Multi-Center, Prospective, Randomized, Double-Blind, P

  Duprez, D.

  PHARMANET, INC.

  1/18/12 → 11/22/12

  Project: Research project

• A Multi-Center, Prospective, Long-term, Observational

  Sudel, B.

  Janssen Biotech, Inc.

  3/12/08 → 12/31/27

  Project: Research project

• A Multicenter, Prospective, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study of BB3 toReduce the Severity of Delayed Graft Function in Recipients of a Deceased Donor Kidney

  Matas, A. J.

  Angion Biomedica Corp.

  4/1/18 → 6/30/22

  Project: Research project

• A Multi-Center, Post Approval Study Providing Continued

  John, R.

  HEARTWARE INTERNATIONAL, INC.

  1/10/13 → 12/31/18

  Project: Research project

• A Multicenter, Placebo-Controlled, Double Blind

  Schwarzenberg, S. J.

  Cystic Fibrosis Foundation

  7/1/16 → 10/31/19

  Project: Research project

• A Multi-Center, Phase III, Randomized Trial of Reduced

  Brunstein, C. G.

  National Marrow Donor Program

  7/1/12 → 7/31/22

  Project: Research project

• A Multicenter, Phase III, Randomized, Placebo-Controlled

  Yee, D.

  Fairview Health Services

  4/19/06 → 4/15/10

  Project: Research project

• A multicenter, Phase 3, randomized, open label, active-c

  Miller, B. S.

  ASCENDIS PHARMA, INC.

  9/1/16 → 9/30/21

  Project: Research project

• A Multicenter, Partially-Masked, Randomized, Controlled Study of Medical Therapy vs.Medical Therapy plus Optic Nerve Sheath Fenestration vs. Medical Therapy plusStereotactic Ventriculoperitoneal Cerebrospinal Fluid Shunting in Subjects with Idiopathic

  Lee, M.

  MOUNT SINAI SCHOOL OF MEDICINE

  7/1/18 → 12/31/19

  Project: Research project

• A Multicenter, Open-Label Trial to Evaluate the Safety

  Hutchins, J. L.

  ACELRX PHARMACEUTICALS, INC.

  3/15/16 → 3/14/19

  Project: Research project

• A Multicenter, Open-Label Study to Evaluate the Safety a

  Orza, F. M. & Hutchins, J. L.

  PACIRA PHARMACEUTICALS, INC.

  6/8/15 → 7/24/15

  Project: Research project

• A Multicenter, Open-Label Study to Evaluate the Safety

  Tuite, P. J.

  BIOTIE THERAPIES, INC.

  6/15/17 → 2/28/20

  Project: Research project

• A Multicenter, Open-label Study to Assess Hospitalizatio

  Olson, S. C.

  Labcorp Drug Development

  1/2/12 → 6/30/14

  Project: Research project

• A Multicenter, Open-Label Study of CMX001 Treatment of S

  Young, J. H.

  Chimerix, Inc.

  11/30/10 → 12/31/12

  Project: Research project

• A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects WithSelected Solid Tumors

  Antonarakis, E. & Rao, A.

  EISAI MEDICAL RESEARCH INC.

  4/1/18 → 4/30/23

  Project: Research project

• A Multicenter, Open-Label Phase 1b/2 Study of Ibrutinib

  Arora, M.

  PHARMACYCLICS, INC.

  6/1/14 → 8/30/19

  Project: Research project

• A MULTICENTER, OPEN-LABEL EXTENSION STUDY TO EVALUATE TH

  Raymond, G. V.

  PAREXEL INTERNATIONAL, LLC

  3/1/17 → 2/28/21

  Project: Research project

• A Multi-Center, Open-Label BMN-110 US Expanded Access Pr

  Whitley, C. B.

  BIOMARIN PHARMACEUTICAL, INC.

  12/31/13 → 11/30/14

  Project: Research project

• A Multi-center, Open Label, Randomized Phase 2 Study of

  Gupta, S.

  ASTELLAS PHARMA, INC.

  6/1/16 → 12/31/17

  Project: Research project

• A Multicenter, Open-Label, Randomized, Phase II/III Stud

  Ondrey, F. G.

  Oxigene, Inc.

  6/21/07 → 10/3/11

  Project: Research project

• A Multi-Center, Open-Label, Parallel-Group, Randomized,

  Olson, S. C.

  SOLVAY PHARM

  12/22/06 → 4/30/08

  Project: Research project

• A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients with Progressive Supranuclear Palsy Who Participated in Study CN002003

  Tuite, P. J.

  BIOGEN INC

  10/11/18 → 3/31/20

  Project: Research project

• A Multicenter, Open-Label, Long-Term Treatment Study

  Tuite, P. J.

  BRISTOL-MYERS SQUIBB COMPANY

  4/1/16 → 3/31/19

  Project: Research project